Innovating Works

UDG

Desconocido
Chromatin3D: Chromatin Dynamics in Development and Disease UDGENOMED MEDICAL GENOMIC TECHNOLOGIES KUTATASFEJLESZTESI ES SZOLGALTATO KFT participó en un H2020: H2020-MSCA-ITN-2014 The cell nucleus is organized and compartmentalized into a highly ordered structure that contains DNA, RNA, chromosomal and histone proteins...
2014-12-12 - 2018-12-31 | Financiado
TARGETAMD: Transposon based targeted ex vivo gene therapy to treat age related macular degeneration AMD UDGENOMED MEDICAL GENOMIC TECHNOLOGIES KUTATASFEJLESZTESI ES SZOLGALTATO KFT participó en un FP7: Age-related Macular Degeneration (AMD), a neurodegenerative disease of the retina, is a major cause of blindness in elderly people. Due to t...
Financiado
NR-NET: Control of metabolic and inflammatory pathways by nuclear receptors UDGENOMED MEDICAL GENOMIC TECHNOLOGIES KUTATASFEJLESZTESI ES SZOLGALTATO KFT participó en un FP7: NR-NET is a multidisciplinary consortium, whose activities are directed towards the understanding of the role of Nuclear Receptors (NRs) and...
Financiado
TRANSPATH: Transglutaminase in disease a novel therapeutic target? UDGENOMED MEDICAL GENOMIC TECHNOLOGIES KUTATASFEJLESZTESI ES SZOLGALTATO KFT participó en un FP7: TRANSPATH is a multisectorial Network designed to facilitate the exchange of knowledge and technology between 7 leading European research te...
Financiado
TRANSCOM: The Commercialisation of Transglutaminase. UDGENOMED MEDICAL GENOMIC TECHNOLOGIES KUTATASFEJLESZTESI ES SZOLGALTATO KFT participó en un FP7: The TRANSCOM project is designed to facilitate the exchange of knowledge and technology between 3 leading European research teams and 4 SMEs...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.